pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·13m ago·1 min read
save

More lawmakers stake out stances on China biotech investment

Nov 20, 2026·read at Endpoints ↗

Ahead of a Democrat-led Congress next year, more lawmakers in both parties and chambers are taking fresh positions on whether the US should restrict investments in China’s booming biotech sector. As shown in multiple draft ...

source

Reporting by Endpoints.

read at Endpoints ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 3h agoPharma layoffs continue in New Jersey; Bausch + Lomb drug misses endpointEndpoints
  • 3h agoKRAS at Triple Meeting: Erasca wants to one-up RevMed, while Alterome tries a different approachEndpoints
  • 4h agoMerck gets another Phase 3 win for sac-TMT, this time in gastric cancerEndpoints
  • 7h agoCelldex culls eczema study after Phase 2 failureEndpoints
  • 7h agoCNS dispatches from Jefferies: Acadia’s search for deals, Alto’s psychiatry question and ProMIS’ Alzheimer’s ambitionsEndpoints